Community cancer care linked with poorer outcomes for some head/neck cancers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Care for patients with human papillomavirus (HPV)-related squamous cell cancers of the oropharynx (an area in back of the throat) is shifting toward community cancer centers, but patients treated in this setting may be less likely to survive, according to new research by investigators from the Johns Hopkins Kimmel Cancer Center and its Head and Neck Cancer Center.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Recently, HHS Secretary Robert F. Kennedy Jr. posted a video montage featuring himself shirtless in jeans, working out with Kid Rock. The duo is in a blue-lit grotto with a cold plunge and sauna. Set to Kid Rock’s “Bawitdaba” and intercut with a selection of patriotic imagery, the video ends with the two men in a hot tub, chugging what appears to be milk.
A three-year grant from Lilly to Roswell Park Comprehensive Cancer Center is bringing rich lung health resources to Indigenous workplaces located across North America. Collaborating with human resources specialists with Tribal Nations and communities covering many regions of the U.S. and Canada, Roswell Park’s Department of Indigenous Cancer Health team will provide lung cancer screening workflow resources, lung wellness education, and patient navigation services for thousands of eligible individuals.
Data from the phase Ib/II OrigAMI-4 study found that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination with a PD-1 inhibitor delivered clinically meaningful and durable antitumor activity in patients with head and neck squamous cell carcinoma that is recurrent or metastatic, PD-L1-positive, and HPV-unrelated. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login